Skip to main content
Livermore
Livermore
ZHEN

Aligos Therapeutics, Inc.

ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001799448

No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

13F holders, Q2 2024

Institutional positions in Aligos Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
0 vs. Q1 2024
Shares held
47.3M
+1.08M (+2.3%) vs. Q1 2024
Total value
$16.6M
−$28.7M (−63.5%) vs. Q1 2024
New holders
8
11 more added
Sold out
8
13 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 49 institutions
Q1 2021: 52 institutionsQ2 2021: 58 institutionsQ3 2021: 68 institutionsQ4 2021: 71 institutionsQ1 2022: 76 institutionsQ2 2022: 60 institutionsQ3 2022: 52 institutionsQ4 2022: 39 institutionsQ1 2023: 46 institutionsQ2 2023: 41 institutionsQ3 2023: 36 institutionsQ4 2023: 40 institutionsQ1 2024: 49 institutionsQ2 2024: 49 institutionsQ3 2024: 27 institutionsQ4 2024: 34 institutionsQ1 2025: 35 institutionsQ2 2025: 37 institutionsQ3 2025: 33 institutionsQ4 2025: 41 institutionsQ1 2026: 35 institutionsQ2 2026: 31 institutions
Value heldQ2 2024: $16.6M
Q1 2021: $612.4MQ2 2021: $550.5MQ3 2021: $483.9MQ4 2021: $390.4MQ1 2022: $68.4MQ2 2022: $36.0MQ3 2022: $30.4MQ4 2022: $25.3MQ1 2023: $23.9MQ2 2023: $25.5MQ3 2023: $19.2MQ4 2023: $30.1MQ1 2024: $45.3MQ2 2024: $16.6MQ3 2024: $14.7MQ4 2024: $64.5MQ1 2025: $27.1MQ2 2025: $19.5MQ3 2025: $26.0MQ4 2025: $26.2MQ1 2026: $20.6MQ2 2026: $13.2M
Institutions holding ALGS and their total value by quarter
QuarterHoldersValue
Q2 202631$13.2M
Q1 202635$20.6M
Q4 202541$26.2M
Q3 202533$26.0M
Q2 202537$19.5M
Q1 202535$27.1M
Q4 202434$64.5M
Q3 202427$14.7M
Q2 202449$16.6M
Q1 202449$45.3M
Q4 202340$30.1M
Q3 202336$19.2M
Q2 202341$25.5M
Q1 202346$23.9M
Q4 202239$25.3M
Q3 202252$30.4M
Q2 202260$36.0M
Q1 202276$68.4M
Q4 202171$390.4M
Q3 202168$483.9M
Q2 202158$550.5M
Q1 202152$612.4M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding ALGS in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC7,256,410$2.54M0.07%+363,000+5.3%Added
EcoR1 Capital, LLC6,389,468$2.24M0.07%00.0%Unchanged
Deep Track Capital, LP6,102,770$2.14M0.06%00.0%Unchanged
Adage Capital Partners GP, L.L.C.5,000,000$1.75M0.00%+2,535,495+102.9%Added
Vivo Capital, LLC3,547,030$1.24M0.11%00.0%Unchanged
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)3,121,689$1.09M0.03%+1,215,498+63.8%Added
Baker Bros. Advisors LP2,076,400$726.7K0.01%00.0%Unchanged
Tang Capital Management LLC1,650,000$577.5K0.06%00.0%Unchanged
Vanguard Group Inc1,595,359$558.4K0.00%+582,292+57.5%Added
Versant Venture Management, LLC1,457,937$510.3K0.66%−862,444−37.2%Reduced
Opaleye Management Inc.1,260,000$441.0K0.10%−370,000−22.7%Reduced
UBS Oconnor LLC1,000,000$350.0K0.01%+500,000+100.0%Added
Acadian Asset Management LLC829,485$289.0K0.00%+171,490+26.1%Added
Bank of America Corp816,029$285.6K0.00%−331,698−28.9%Reduced
Renaissance Technologies LLC768,839$269.1K0.00%−39,421−4.9%Reduced
Pivotal bioVenture Partners Investment Advisor LLC743,215$260.1K0.20%00.0%Unchanged
Newtyn Management, LLC719,287$251.8K0.05%−480,713−40.1%Reduced
Silverarc Capital Management, LLC655,515$229.4K0.06%00.0%Unchanged
Woodline Partners LP531,204$185.9K0.00%+531,204New
Geode Capital Management, LLC405,694$142.0K0.00%+32,638+8.7%Added
Alyeska Investment Group, L.P.284,233$99.5K0.00%+284,233New
Citadel Advisors LLC277,363$97.1K0.00%−8,316−2.9%Reduced
BlackRock Inc.227,406$79.6K0.00%−76,349−25.1%Reduced
State Street Corp107,123$37.5K0.00%+9,700+10.0%Added
Northern Trust Corp91,950$32.2K0.00%−65−0.1%Reduced
LMR Partners LLP50,000$17.5K0.00%+50,000New
Tower Research Capital LLC (TRC)46,476$16.3K0.00%+38,454+479.4%Added
XTX Topco Ltd35,644$12.5K0.00%−9,227−20.6%Reduced
Charles Schwab Investment Management Inc31,383$11.0K0.00%00.0%Unchanged
Millennium Management LLC29,881$10.5K0.00%−80,780−73.0%Reduced
Choate Investment Advisors24,000$8.40K0.00%00.0%Unchanged
Prudential Financial Inc19,600$6.86K0.00%+19,600New
HarbourVest Partners LLC18,783$6.57K0.00%00.0%Unchanged
Two Sigma Investments, LP18,706$6.55K0.00%+82+0.4%Added
CWM, LLC16,891$6.00K0.00%00.0%Unchanged
ZWJ Investment Counsel Inc14,500$5.08K0.00%00.0%Unchanged
Jane Street Group, LLC13,666$4.78K0.00%+13,666New
Zullo Investment Group, Inc.13,000$4.55K0.00%00.0%Unchanged
HighTower Advisors, LLC10,000$4.00K0.00%+10,000New
Virtu Financial LLC12,306$4.00K0.00%+12,306New
Creative Planning10,050$3.52K0.00%−5,475−35.3%Reduced
Advisor Group Holdings, Inc.5,500$1.93K0.00%+5,500New
Morgan Stanley3,300$1.16K0.00%00.0%Unchanged
JPMorgan Chase & Co677$2370.00%00.0%Unchanged
UBS Group AG362$1270.00%−10,463−96.7%Reduced
ZRC Wealth Management, LLC100$350.00%00.0%Unchanged
Simplex Trading, LLC208$00.00%−896−81.2%Reduced
Qube Research & Technologies Ltd2$00.00%00.0%Unchanged
Royal Bank of Canada511$00.00%+387+312.1%Added
Altitude Crest Partners Inc.0$00.00%−2,844,681−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−92,000−100.0%Sold out
Atom Investors LP0$00.00%−34,173−100.0%Sold out
Procyon Private Wealth Partners, LLC0$00.00%−20,000−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−12,500−100.0%Sold out
Financial Advocates Investment Management0$00.00%−10,000−100.0%Sold out
Total Clarity Wealth Management, Inc.0$00.00%−10,000−100.0%Sold out
Wells Fargo & Company0$00.00%−298−100.0%Sold out